Study Comparing Pharmacokinetics of Different Formulations of Evobrutinib in Healthy Participants

Condition:   Healthy Interventions:   Drug: Ref (TF2);   Drug: Evobrutinib MR-T1;   Drug: Evobrutinib MR-T2;   Drug: Evobrutinib MR-T3;   Drug: Evobrutinib MR-T4;   Drug: Evobrutinib MUPS-C1;   Drug: Evobrutinib MUPS-C2;   Drug: Evobrutinib MUPS-C3;   Drug: Evobrutinib MUPS-C4 Sponsors:   Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany;   Merck KGaA, Darmstadt, Germany Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials